Smoking has been shown to have a large, reliable, and rapid effect on demethylation of AHRR, particularly at cg05575921, suggesting that methylation may be used as an index of cigarette consumption. Because the availability of methyl donors may also influence the degree of demethylation in response to smoking, factors that affect the activity of methylene tetrahydrofolate reductase (MTHFR), a key regulator of methyl group availability, may be of interest. In the current investigation, we examined the extent to which individual differences in methylation of MTHFR moderated the association between smoking and demethylation at cg05575921 as well as at other loci on AHRR associated with a main effect of smoking. Using a discovery sample (AIM, N = 293), and a confirmatory sample (SHAPE, N = 368) of young adult African Americans, degree of methylation of loci in the first exon of MTHFR was associated with amplification of the association between smoking and AHRR demethylation at cg05575921.
| INTRODUCTION
Smoking has enormous implications for population-level health in the United States. Smoking consistently ranks as the single greatest preventable cause of morbidity and mortality in the United States, with documented effects on increased risk for cancer, type 2 diabetes, chronic obstructive pulmonary disease, and obesity (Centers for Disease Control and Prevention, 2008) . Smoking causes nearly half a million US deaths per year along with higher population rates of preventable, serious illness (Mokdad, Marks, Stroup, & Gerberding, 2004 ). This burden is not distributed equally. Among US residents, people of African descent suffer worse outcomes for smoking-related illnesses (Centers for Disease Control and Prevention, 2010, November 26; Haiman et al., 2006) , even after adjusting for common covariates such as socioeconomic status (SES) and healthcare access.
This suggests that examination of African American samples could create a better understanding of other factors which interact with smoking to alter future risk for morbidity and mortality.
| The use of cg05575921 as an indicator of smoking intensity
A significant barrier to a better understanding of the impact of smoking on health outcomes has been the lack of good biomarkers of cigarette consumption. However, recently several groups have demonstrated that smoking is associated with changes in DNA methylation (Breitling, Yang, Korn, Burwinkel, & Brenner, 2011; Joubert et al., 2012; Monick et al., 2012; Philibert, Beach, Lei, & Brody, 2013; Shenker et al., 2013; Zeilinger et al., 2013) . These studies have shown that longer-term smoking in older adults is associated with widespread and extensive remodeling of DNA methylation, particularly at loci associated with inflammation or toxin metabolism. In contrast, the extent of genome wide remodeling is much less extensive for nascent smokers or those with less smoking history (Philibert et al., , 2013 , with changes often confined to the aryl hydrocarbon receptor repressor (AHRR). This observation led to the proposal that measurement of a single CpG residue on AHRR (cg05575921) might suffice for accurate detection of nascent smoking in many cases, allowing an enhanced role for testing in pediatric care (Beach, Gerrard, Gibbons, Brody, & Philibert, 2015) . In addition, this observation suggests that examination of factors influencing smoking-related demethylation may be simplified among those with recent onset because attention can be focused on AHRR.
The biochemical basis for sensitivity to cigarette smoking of methylation status at cg05575921 is the large amounts of dioxin and poly aromatic hydrocarbons (PAH) found in tobacco smoke (Talhout et al., 2011) . When these and other toxins from cigarette smoke are inhaled and absorbed by blood passing through the lungs, there is a robust cellular response by white blood cells and pulmonary macrophages. This response includes activation of the aryl hydrocarbon receptor (AHR), a nuclear receptor which is the key regulator of the xenobiotic response, leading to activation of CYP1A1, CYP1A2, and CYP1B1. Because the unrestrained activity of these and other cytochromes can result in generation of reactive oxygen species (ROS), catabolism of key cellular components, and potentially carcinogenesis (Ramadoss, Marcus, & Perdew, 2005) , the xenobiotic response system is under tight regulatory control. A second nuclear receptor, AHRR, serves as a feedback modulator of the effects of AHR activation, competing for the obligate heterodimer partner of AHR, the aryl hydrocarbon nuclear translocator, and for DNA binding motifs for AHR. The enhancer region of AHRR that includes cg05575921 plays a key role in this increase in AHRR activity. Zeilinger et al. (2013) have shown the cg05575921 demethylation is associated with the disassociation of the repressive protein complex and the recruitment of transcriptional activators. As a result, excessive activity of the xenobiotic pathway is avoided. One direct consequence of this regulatory cycle is that methylation of AHRR, and specifically the region around cg05575921, is an exquisitely sensitive indicator of smoking intensity.
| Do individual differences influence AHRR response to smoking?
Our understanding of the methylomic response to smoking is still incomplete. In particular, one question left unresolved by prior research is whether individual differences in folate-metabolism regulation may be consequential for degree of, or rapidity of, demethylation in response to smoking. Activated methyl groups are required for DNA methylation, regulation of chromatin structure, and maintenance of DNA methylation patterns when cells divide. Accordingly, individual differences affecting availability of activated methyl groups may, in turn, affect maintenance of DNA methylation patterns in replicating cells (Jones & Liang, 2009 ). Because smoking is associated with substantial reductions in plasma folate (Gabriel et al., 2006; Okumura & Tsukamoto, 2011) as well as in red blood cells (Piyathilake et al., 1992; Walmsley, Bates, Prentice, & Cole, 1999 ) and buccal cells (Piyathilake et al., 1992 (Piyathilake et al., , 1995 , even after correcting for folate intake (Piyathilake et al., 1995) , it would be expected that most smoking effects on methylation would be in the direction of demethylation. If so, individual differences that further reduce availability of activated methyl groups could potentially amplify the long-term effect of smoking on genomewide demethylation (Jacob et al., 1998) , and potentially amplify as well the initial response of nascent smokers at AHRR. Identifying sources of individual variability in response to smoking could enhance the ability of methylation based bio-markers to even more sensitively identify smokers as well as correctly quantify level of cigarette consumption based on methylation markers.
| The role of MTHFR in methylation maintenance
Because methylene tetrahydrofolate reductase (MTHFR) is the ratelimiting enzyme in the methyl cycle, a pathway that is critical to folate metabolism, it is a natural focus of attention as a source of potential individual differences that may be consequential for availability of activated methyl groups. Smooth functioning of this cycle maintains adequate levels of S-adenosylmethionine (SAM) in cells, providing a readily available methyl group donor for numerous methylation related reactions (Stover, 2009) , especially genomic methylation. Conceivably, individual differences that are associated with reduced MTHFR activity could lead to reductions in DNA methylation repair over time or increase the rate of loss of methylation in response to stimuli associated with demethylation such as cigarette smoking. Conversely, when MTHFR is more active, methylation of homocysteine should be enhanced, potentially blunting the impact of external factors like smoking that would otherwise lead to demethylation (Stover, 2009 ).
The MTHFR gene is located on chromosome 1, region 1p36.3, and contains 11 exons and three alternative transcription start sites, all in the vicinity of the first exon (Frosst et al., 1995; Goyette et al., 1994) .
Several polymorphisms that may potentially influence MTHFR activity have been identified, with one of the most commonly cited variants being rs1801133, a C-T substitution at position 677 (C677T) that converts a codon for alanine to one for valine (167A-167V) (Sibani et al., 2000) . The 167V isoform of MTHFR is less active, more thermolabile and is associated with hypohomocyteinemia (Goyette & Rozen, 2000) . Not all ethnicities are affected equally; rs1801133 is in strong population disequilibrium, with the frequency of T allele in African Americans (∼20%) being about half that for those of Northern European ancestry (Sherry et al., 2001 ).
| MTHFR and folate metabolism in disease
Lower activity of MTHFR reduces the synthesis of 5-methylTHF and hence remethylation of homocysteine, an outcome associated with global hypomethylation (Castro et al., 2004; Yi et al., 2000) . In tissue culture, low folic acid levels lead to increased formation of micronuclei, indicating increased rates of chromosome breakage. Further, the low activity MTHFR TT genotype also leads to increased micronuclei formation under low folate conditions (Kimura, Umegaki, Higuchi, Thomas, & Fenech, 2004) , and is associated with global DNA hypomethylation in circulating leukocytes, perhaps in interaction with level of folate (Friso et al., 2002; Stern, Mason, Selhub, & Choi, 2000) . Not surprisingly, variation in folate metabolism also has been linked to increased vulnerability for a number of disease states, including risk of cardiovascular disease, multiple cancers, and neural BEACH ET AL. | 609 tube defects (Erickson, 2002; Holmquist, Larsson, Wolk, & de Faire, 2003; Lamprecht & Lipkin, 2003) . In addition, the MTHFR TT genotype has been shown to increase risk for a wide variety of neuropsychiatric disorders including depression and schizophrenia (Gilbody, Lewis, & Lightfoot, 2007; Lewis, Zammit, Gunnell, & Smith, 2005) as well as a broad behavioral phenotype for psychopathology (Peerbooms et al., 2011) . Accordingly, there is good reason to hypothesize a role for MTHFR, folate metabolism, and their combination in better predicting DNA methylation in response to smoking, with potential implications for vulnerability to longer-term disease outcomes associated with smoking.
Therefore, taken as a whole, there is a substantial body of evidence that suggests that variation in methyl donor availability exists and that it could alter the epigenomic response to smoking. As a first step in the testing of that those possibilities, we examine the relationship between genetic and epigenetic differences in MTHFR and demethylation of cg05575921 in response to smoking.
Specific hypotheses:
H1: Early cumulative smoking will be associated with changes in cg05575921 methylation, even after controlling for the impact of sex, cell type variation, SES, methylation of MTHFR, and in the SHAPE sample genotype at MTHFR C677T .
H2: Because it should down-regulate activity, greater methylation of the first exon of MTHFR will moderate (i.e., intensify) the association of smoking with demethylation of cg05575921, even after controlling for the main effect of smoking and mMTHFR, and the effect of cell-type variability, sex, SES-risk, and in the SHAPE sample, genotypic variation at MTHFR C677T .
H3: Effects will replicate after removing potential false negatives, or those very recently initiating smoking, that is, those denying smoking across all three earlier waves of self-report data collection, but who test positive for cotinine at the time of the blood draw.
H4: Patterns seen at cg05575921 will replicate at other loci on the AHRR gene previously found to be associated with smoking: cg21161138 and cg26703534.
The data utilized are from two longitudinal research projects: the Strong African American Healthy Adult Project (SHAPE; n = 322; see Brody, Yu, Chen, Kogan, and Smith [2012] for a full description) and the Adults in the Making project (AIM; n = 294; see Brody, Yu, Chen, Kogan, and Smith [2012] for a full description). All procedures and protocols conducted in these studies were approved by the University of Georgia Institutional Review Board.
| Initial sample
For the AIM sample, 496 youth were randomly recruited from publicschool lists in six rural Georgia counties; none of which overlapped with those included in SHAPE. Again, the recruitment strategy was designed to obtain a representative sample of African American youth and families. The primary caregivers worked an average of 38. included in the present study revealed no differences on any variables.
| Replication sample
The SHAPE participants and their families were drawn from nine rural counties in Georgia, and so resided in small towns and communities in which poverty rates are among the highest in the nation and unemployment rates are above the national average (DeNavas-Walt & Proctor, 2014). Participants were selected randomly from lists of students that schools provided. Recruitment procedures were designed to obtain a sample of African American youth that was representative of the communities from which it was drawn; no other selection criteria were used. For the 399 (79.8%) who provided blood samples, primary caregivers worked an average of 39.9 hr per week, 42% of the participants lived below federal poverty standards, and they had a median family income of $1,732 per month. The sample for the present study comprises 368 participants (167 men and 201 women) for whom blood was drawn at age 20 and for whom data was successfully genotyped for MTHFR polymorphism. Comparisons between these 368 participants and the 31 participants who were excluded because of incomplete data on genotyping revealed no significant differences on any of the key study variables or confounder variables. Fifty-six participants reported no cigarette use from ages 17-19, but subsequently were found to have cotinine levels >1.
For both samples, all data were collected in participants' homes using standardized protocols. Interviews were conducted privately, with no other family members present or able to overhear the conversation. Participants were compensated $100 at each wave of data collection. Informed-consent forms were completed at all datacollection points.
Self-reported smoking and potential confounder variables were assessed in SHAPE and AIM when the youth were approximately 17- 
| Cigarette consumption
At each wave of data collection in both SHAPE and AIM participants were asked "In the past month, how much did you smoke cigarettes?" Response options included: 0-None at all; 1-Less than one cigarette a day; 2-One to five cigarettes a day; 3-About a half a pack a day; 4-About a pack a day; 5-About one and a half packs a day; 6-About two packs a day.
| Methylation
Certified phlebotomists drew antecubital blood samples of whole blood (30 ml) from each participant and shipped it to a lab in Iowa the same day for preparation. At the lab the blood tubes were inspected to ensure anticoagulation and aliquots of blood were diluted, mononuclear cell pellets were separated from the diluted blood specimen by densitygradient centrifugation, and the mononuclear cell layer was removed from the tube using a transfer pipette, resuspended, and frozen at −80°C until use. Genomic DNA was prepared using a QiaAmp (Qiagen, Hilden, Germany) according to manufacturer's directions. A typical DNA yield for each mononuclear cell pellet was between 10 and 15 μg.
The Illumina (San Diego, CA) HumanMethylation450 Beadchip was used to assess genome-wide DNA methylation. Participants were randomly assigned to 12 sample "slides/chips" with groups of eight slides being bisulfite converted in a single batch, resulting in five "batches/plates." A replicated sample of DNA was included in each plate to aid in assessment of batch variation and to ensure correct handling of specimens. 
| Quantile normalization of methylation data
Quantile normalization methods with separate normalization of Types I and II assays in the Illumina array produce marked improvement in detection of relationships by correcting distributional problems inherent in the manufacturers default method for calculating β (i.e., β = M/(M + U + 100; where M and U are methylated and unmethylated signal intensities, respectively [Pidsley et al., 2013] ). Accordingly, in the current investigation all loci across all plates were quantile normalized concurrently, separating methylated and unmethylated intensities, and using the wateRmelon R package (Pidsley et al., 2013) , a mutation associated with decreased activity of MTHFR (Frosst et al., 1995 
| Plan of analysis
We utilized beta regression analyses in all cases because the dependent variable (degree of methylation) is calculated as a ratio of methylated to unmethylated loci ranging from zero to one, and so typically fails the assumption of having a normal distribution (Dolzhenko & Smith, 2014) .
Beta regressions, utilizing the beta distribution, were introduced by (Ferrari & Cribari-Neto, 2004) , and are useful when the dependent variable is bounded, or when it has a ceiling or floor effect, introducing a non-normal distribution for the dependent variable.
On step 1 of each beta regression, we entered the main effect of cumulative self-reported smoking across three years in early adulthood.
Accordingly, we examined the impact of self-reported smoking in a multivariate context, controlling for the effect of sex, cell-type variation, and in the case of the SHAPE sample, genotype at MTHFR
C677T
. On the second step we examined the additional main effect of mMTHFR, again accounting for multivariate influences, and on the third step we examined the effect of adding the interaction term, mMTHFR × cumulative smoking, and in the case of the SHAPE sample, we also added the interaction term of genotype at MTHFR C677T × cumulative smoking. This basic series of steps is repeated across both the SHAPE and AIM samples as well as for the reduced samples resulting from the removal of potential false negatives, i.e., anyone reporting no cigarette use, but nonetheless, found to have elevated cotinine at the time of the blood draw. In the supplemental materials we provide similar regression analyses for the two additional loci on AHRR (cg21161138 and cg26703534) that typically show main effect associations with nascent smoking. We also report parallel effects for an index comprising all 24 loci annotated as being associated with AHRR and an index comprising the 18 AHRR loci that have no annotated local SNP variation, minimizing potential cis effects.
4 | RESULTS
| Hardy-Weinberg
Genotype at MTHFR C677T was determined for each youth as previously described. Of the sample, 1.1% were homozygous for the low activity T allele (TT), 17.1% were heterozygous (CT), and 81.8%
were homozygous for the high activity C allele (CC). The distribution of alleles did not deviate from Hardy-Weinberg equilibrium (p = .731, ns).
| H1:
Early cumulative smoking will be associated with changes in cg05575921 methylation were homozygous). Significant correlations were found between selfreported smoking and cg05575921 and sex, with marginal correlations with cell-type, and a non-significant association with SES-risk in SHAPE and a significant association in AIM.
As can be seen in Tables 2 and 3 , Column 1, even when covariates for sex, SES risk, and cell-type variation were included, cumulative smoking across 3 years in late adolescence continued to be strongly correlated with demethylation of cg05575921, indicating that the association of smoking with demethylation of cg05575921 is robust to covariates, including variation in cell-types comprising the PBMC pellets for each participant.
| H2: Greater mMTHFR will moderate (i.e., intensify) the impact of smoking on demethylation of cg05575921
In Column 2 of Tables 2 and 3, the main effect of mMTHFR was entered and exerted no significant main effect on methylation at cg05575921.
In step 3, the interaction of mMTHFR and level of smoking was entered into the model, resulting in a significant interaction effect in each sample. The significant interaction effect is plotted in Figure 1a (for the AIM sample) and Figure 1b (for the SHAPE sample), showing that, as anticipated, greater methylation at MTHFR was associated with a stronger effect of smoking on demethylation of cg05575921 in response to cumulative smoking. As can be seen in Table 3 , in the SHAPE sample there was no significant interaction effect of genetic variation at MTHFR 667 with smoking, showing that variation at this locus did not account for the observed moderating effect of mMTHFR on the impact of smoking.
4.4 | H3: Effects will replicate in the reduced sample that excludes those denying smoking despite testing positive for cotinine
To examine the effect of eliminating potential false negatives, we eliminated cotinine positive participants who denied smoking at all prior waves of data collection, thereby reducing potential error due to underreporting or recent onset of smoking. Accordingly, we replicated the findings reported above using only the cotinine verified participants in each sample (Table 4 for AIM and Table 5 for SHAPE).
In each case the results replicated exactly. There is a robust effect of smoking on methylation at cg05575921 controlling potential confounding variables, and the interaction of mMTHFR with smoking continues to be significant in the direction of an intensified demethylation response among those with greater methylation of MTHFR. Graphical explication of the interaction effects for Tables 4 and 5, replicating the pattern previously portrayed in Figure 1a ,b are available in the supplemental materials ( Figure S1a,b) .
4.5 | H4: Effects will replicate for other AHRR loci typically found to be associated with smoking: cg21161138 and cg26703534
To examine replication of a similar interaction pattern for the two other loci on AHRR previously found to be associated with nascent smoking (Philibert et al., 2013) , we re-ran regression analyses substituting methylation at these loci as outcomes in place of cg05575921. In both samples there was a significant main effect of self-reported smoking on demethylation at the additional AHRR loci.
Significant moderation of smoking's impact attributable to mMTHFR was found for both additional AHRR loci in the AIM sample (see supplemental tables S1a and S2a) and for one of the additional loci (cg21161138) in the SHAPE sample (see supplemental Table S1b ). At the second locus (cg26703534), the interaction was marginal in the SHAPE sample (p = .067), albeit in the same direction as the other significant effects (see supplemental Table S2b ). In all cases, the significant interaction of mMTHFR with smoking resulted in an intensification of the demethylation response among those with greater methylation of MTHFR. The graphical explication of the significant interaction effects are available in the supplemental materials (Supplemental Figure S2a-c) .
| DISCUSSION
The initiation of smoking prompts a strong response by the xenobiotic pathway, leading to demethylation, particularly at cg05575921, but also secondarily at other CpG sites, particularly those on AHRR. This effect has been replicated in a number of samples (Elliott et al., 2014; Monick et al., 2012; Philibert et al., 2013; Shenker et al., 2013; Zeilinger et al., 2013; Zhang et al., 2014 ) and appears to be robust across ethnicities (Dogan et al., 2015) . This impact of smoking on cg05575921 methylation is not surprising given the key biological role played by AHRR in response to the types of toxins commonly found in cigarette smoke. The current investigation adds to this finding by showing for the first time that the impact of smoking on demethylation of cg05575921 is potentially qualified by an epigenetic regulatory motif: methylation of the first exon of MTHFR.
Despite the success of cg05575921 as an early and sensitive indicator of incipient smoking and changes in smoking status, it is not perfectly correlated with self-reported smoking, a limitation likely due, in part, to problems inherent in self-report (e.g., Philibert et al. [2013] ).
When self-report errors are minimized, for example, by excluding individuals whose cotinine level suggests they are smokers even though they deny smoking, the correlation of smoking with cg05575921 methylation typically increases. However, there is Correlations for SHAPE data (N = 368) displayed below the diagonal; correlations for AIM data (N = 293) displayed above the diagonal. MTHFR polymorphism is not available for AIM data. **p ≤ .01; *p ≤.05; †p < .10 (twotailed tests).
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| 613 sufficient variability in methylation levels among youth reporting similar, low levels of smoking, to suggest the presence of other individual difference factors moderating the impact of nascent smoking experience on demethylation of cg05575921. Such sources of variability will be particularly important when accurate quantification of prior smoking exposure is a primary goal rather than simply differentiating smokers and non-smokers. As outlined above, a potential source of such variability is individual differences in in activity of MTHFR.
In the current investigation, we found replicated evidence that for African American youth, the impact of self-reported smoking on demethylation of cg05575921 was intensified when methylation of the first exon of MTHFR was elevated. This is significant theoretically because it suggests that in the context of a strong stimulus favoring demethylation, like cigarette smoking, it is possible to observe direct regulatory impact of AHRR methylation patterns on the epigenetic impact of smoking. The interaction was predicted on the basis of expectations that methylation of a first exon would have a strong Unstandardized coefficients (β) and odds ratio (e β ) shown with standard errors in parentheses; SES-related risk are standardized by z-transformation. n = 293. † p ≤ .10, *p ≤ .05, **p ≤ .01 (two-tailed tests). Unstandardized coefficients (β) and odds ratio (e β ) shown with standard errors in parentheses; SES-related risk are standardized by z-transformation. n = 368. † p ≤ .10, *p ≤ .05, **p ≤ .01 (two-tailed tests).
impact on reduced expression and hence reduced activity of a gene that is central to folate metabolism. Accordingly, elevated methylation of the first exon of AHRR was expected to result in better maintenance of methylation at cg05575921 and so less apparent effect of smoking. It is noteworthy that the same pattern was replicated for two other AHRR loci known to be influenced by smoking. In addition, we examined the effect using average methylation across all loci annotated as being associated with MTHFR regardless of location on the gene and found that the pattern was again replicated, suggesting that observation of the pattern does not depend on restricting attention to the first exon (See supplemental Table S3a and b and Figure S3a,b) . Finally, when six loci that were on or close to known SNPs on MTHFR (Table S4) were dropped from the index, overall MTHFR methylation continued to moderate the impact of smoking on methylation at cg05575921 (see supplemental Table S5a and S5b as well as supplemental Figure S4a,b) , suggesting that the moderating effect was not due to cis effects of cryptic genotypic variation within MTHFR.
Some limitations of the current analyses should also be noted.
First, given the centrality of the folate cycle to a broad range of biological activities, it is possible that the index of mMTHFR used in the current study is itself correlated with broader patterns of methylation, and so with variability in other gene regulatory motifs across the genome, resulting in coordinated pattern of change. If so, it may be useful in future research, using larger samples, to examine such broader networks. By necessity this will include both broader sampling of methylation of other folate cycle genes, sampling of sera to determine folate levels, consideration of dietary factors including alcohol intake, and possibly gut biome interactions. Because many of these potentially independent influences will be correlated, the study of cohorts for whom multiple levels of biological data are available should be emphasized. Likewise, no mRNA was available for the current samples and so we were not able to examine the hypothesized effect of mMTHFR on gene activity. Fortunately, because the loci utilized in the current investigation are included in the Illumina 450 K array, the hypotheses advanced in the current study can be examined in any data set that includes both an assessment of smoking and Illumina 450 K array data.
With regard to practical implications for assessment, the current results suggest that when demethylation of cg05575921 is used as a basis to quantify recent smoking history, it may be useful to examine mMTHFR as well. In the current investigation, the interaction term accounted for between 2.1% and 1.5% of the variance in demethylation of cg05575921in response to smoking for the SHAPE and AIM cotinine verified samples, respectively. Likewise, for all levels of consumption beyond zero and "less than one per day," that is, the two lowest levels of self-reported cigarette consumption, the level of demethylation in response to smoking differed significantly for those with higher versus lower mMTHFR.
For example, in the cotinine verified SHAPE sub-sample, someone with low mMTHFR who was found to have 80% methylation of cg0557592, would be estimated to have been a heavy smoker, over the past several years, with cigarette consumption in the range of "1 and a half packs a day"; which is a five on our self-report scale.
Conversely, someone with high mMTHFR who was found to have the same level of methylation at cg0557592 would be estimated to be only a light smoker, with cigarette consumption in the range of "1-5 cigarettes a day"; a two on our self-report scale. Accordingly, there
are potentially large differences in estimated cigarette exposure FIGURE 1 a. Explication of significant interaction effect in Table 2 for AIM sample. Beta regression examining effects of cigarette use at ages 17-19 on cg05575921 moderated by mMTHFR (n = 293) using all available participants. b. Explication of significant interaction effect in Table 3 for SHAPE sample. Effects of cigarette use at ages 17-19 on cg05575921 moderated by mMTHFR (n = 293) using all available participants BEACH ET AL.
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If the current findings are replicated more broadly, including replication in samples of longer-term smokers, it will be of interest to see if smoking's broader effects on demethylation genomewide are also moderated by regulatory motifs influencing the folate cycle. If so, such variability will be an attractive target for explication of individual differences in morbidity and mortality that are associated with smoking exposure. Specifically, it may be that cg05575921 demethylation can serve as a "canary in the coal mine," providing an early forecast of patterns of epigenetic change likely to emerge with continued smoking, helping to identify individuals at greatest risk for smoking associated health complications.
TABLE 4 AIM. Beta regression models depicting moderating effects of variation at the mMTHFR on cg05575921, excluding (n = 40) individuals who self-reported no cigarette use across three waves from 17 to 19, but had cotinine value >1. Unstandardized coefficients (β) and odds ratio (e β ) shown with standard errors in parentheses; SES-related risk are standardized by z-transformation. n = 253. † p ≤ .10, *p ≤ .05, **p ≤ .01 (two-tailed tests).
TABLE 5 SHAPE. Beta regression models depicting moderating effects of variation at the mMTHFR on cg05575921, excluding (n = 56) individuals who self-reported no cigarette use across three waves from 17 to 19, but had cotinine value >1. Unstandardized coefficients (β) and odds ratio (e β ) shown with standard errors in parentheses; SES-related risk are standardized by z-transformation. n = 321. † p ≤ .10, *p ≤ .05, **p ≤ .01 (two-tailed tests).
